Latest news
Cabenuva Beats Daily Oral Therapy in Adolescents With HIV in LATA Trial - Contagion LiveContagion Live · Tue, 04 Aug 2026 12:27:16 GMTGoethe-Zertifikat A2: Fit In Deutsch – Sprechen Jugendliche | German A2 Oral Exam Adolescents Naomi Osaka (NZEelEbxnF) - MshaleMshale · Fri, 31 Jul 2026 15:56:25 GMTLong-acting Cabenuva beats daily oral HIV therapy in adolescents | AIDS 2026 - Managed Healthcare ExecutiveManaged Healthcare Executive · Wed, 29 Jul 2026 07:00:00 GMTCabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT